For the quarter ending 2025-12-31, PETS had -$9,184K decrease in cash & cash equivalents over the period. -$9,184K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net sales | 40,660 | 44,364 | 51,180 | 226,972 |
| Cost of sales | 31,204 | 31,949 | 36,777 | 157,835 |
| Advertising | 5,332 | 4,341 | 6,046 | 23,781 |
| Other segment expenses | 11,682 | 10,389 | 11,054 | 44,684 |
| Adjusted ebitda | -7,558 | -2,315 | -2,697 | 672 |
| Share-based compensation expense (reversal) | 254 | 248 | 591 | -6,586 |
| Income taxes | 11 | 9 | 9 | 5,684 |
| Depreciation and amortization | 2,399 | 2,278 | 2,283 | 7,039 |
| Interest (income) expense, net | -221 | -326 | -198 | 185 |
| Acquisition/partnership transactions and other items | 0 | 0 | 0 | 231 |
| Employee severance | 9 | 1,224 | 95 | 738 |
| Sales tax expense (income) | 0 | 0 | - | -1,178 |
| Professional fees | 101 | 2,120 | 1,021 | - |
| Impairment of goodwill and intangible assets | 0 | 0 | 27,258 | 1,200 |
| Net (loss) income | -10,553 | -8,520 | -34,152 | -6,271 |
| Depreciation and amortization | 2,399 | 2,278 | 2,283 | 7,039 |
| Impairment of goodwill and intangible assets | 0 | 0 | 27,258 | 1,200 |
| Inventory write-down | 2,126 | - | - | - |
| Share based compensation | 254 | 248 | 591 | -6,586 |
| Deferred income taxes | 0 | 0 | 0 | 5,249 |
| Bad debt (recovery) expense | -19 | 12 | -6 | 365 |
| Accounts receivable | -425 | 372 | -718 | -601 |
| Inventories, net | -436 | -3,593 | 2,156 | -12,351 |
| Prepaid income taxes | -5 | -36 | 0 | 111 |
| Prepaid expenses and other current assets | 1,208 | -139 | 1,170 | -995 |
| Operating lease right-of-use assets, net | -114 | -113 | -112 | -466 |
| Accounts payable | 1,181 | -922 | -3,523 | -13,460 |
| Sales tax payable | -133 | 289 | 127 | -145 |
| Accrued expenses and other current liabilities | -3,953 | 1,264 | -1,287 | 3,921 |
| Lease liabilities | -116 | -115 | -113 | -458 |
| Deferred revenue | -163 | -113 | -977 | -518 |
| Income taxes payable | 0 | -104 | 24 | 80 |
| Net cash used in operating activities | -9,205 | -2,174 | -12,271 | 4,718 |
| Purchase of minority interest investment in vetster | - | - | - | 0 |
| Acquisition of petcarerx, net of cash acquired | - | - | - | 0 |
| Purchases of property and equipment | -21 | 2,624 | 1,292 | 5,113 |
| Net cash used in investing activities | 21 | -2,624 | -1,292 | -5,113 |
| Dividends paid | 1 | 22 | 1 | 181 |
| Cash paid for tax withholding on net settlement of restricted stock | -1 | 209 | 29 | - |
| Net cash used in financing activities | 0 | -231 | -30 | -181 |
| Net decrease in cash and cash equivalents | -9,184 | -5,029 | -13,593 | -576 |
| Cash and cash equivalents at beginning of period | 36,098 | 41,127 | 54,720 | 55,296 |
| Cash and cash equivalents at end of period | 26,914 | 36,098 | 41,127 | 54,720 |
PETMED EXPRESS INC (PETS)
PETMED EXPRESS INC (PETS)